Ease Fears About Breast Cancer Risk With Hormonal Contraception
New evidence will reignite controversy about breast cancer risk with hormonal contraceptives.
The lower estrogen doses and different progestins in newer hormonal contraceptives were generally thought to be safer than the older ones.
Now a study suggests that newer hormonal contraceptives also raise breast cancer risk by about 20%...similar to older options.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote